Phoenix, AZ4 Active Studies

Heart Disease Clinical Trials in Phoenix, AZ

Find 4 actively recruiting heart disease clinical trials in Phoenix, AZ. Connect with local research sites and explore new treatment options.

4
Active Trials
3
Sponsors
40,936
Enrolling

Recruiting Heart Disease Studies in Phoenix

RecruitingPhoenix, AZNCT06292013

A Study to Investigate the Effect of Lepodisiran on the Reduction of Major Adverse Cardiovascular Events in Adults With Elevated Lipoprotein(a) - ACCLAIM-Lp(a)

The purpose of this study is to evaluate the efficacy of lepodisiran in reducing cardiovascular risk in participants with high lipoprotein(a) who have cardiovascular disease or are at risk of a heart ...

16,700 participants
Eli Lilly and Company
View Study Details
RecruitingPhoenix, AZNCT07037433

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

The primary objective of this trial is to demonstrate that maridebart cafraglutide is superior to placebo when given as an adjunct to standard of care with respect to reducing cardiovascular (CV) morb...

12,800 participants
Amgen
View Study Details
RecruitingPhoenix, AZNCT07136012

OCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events

The primary objective is to evaluate the effect of olpasiran, compared to placebo, on the risk for coronary heart disease death (CHD death), myocardial infarction, or urgent coronary revascularization...

11,000 participants
Amgen
View Study Details
RecruitingPhoenix, AZNCT05918211

Fontan Udenafil Exercise Longitudinal Assessment Trial - 2

This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo for the treatment of adolescent who have had the F...

436 participants
Mezzion Pharma Co. Ltd
View Study Details

About Heart Disease Clinical Trials in Phoenix

Heart disease is the leading cause of death worldwide, encompassing conditions that affect the heart and blood vessels. Coronary artery disease, the most common type, occurs when arteries supplying the heart become narrowed or blocked. Risk factors include high blood pressure, high cholesterol, diabetes, and smoking.

There are currently 4 heart disease clinical trials recruiting participants in Phoenix, AZ. These studies are seeking a combined 40,936 participants. Research is being sponsored by Eli Lilly and Company, Amgen, Mezzion Pharma Co. Ltd. Clinical trial participation is free and participants receive study-related medical care at no cost.

Heart Disease Clinical Trials in Phoenix — FAQ

Are there heart disease clinical trials in Phoenix?

Yes, there are 4 heart disease clinical trials currently recruiting in Phoenix, AZ. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Phoenix?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Phoenix research site will contact you about next steps.

Are clinical trials in Phoenix free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Phoenix studies also compensate for your time and travel.

What heart disease treatments are being tested?

The 4 active trials in Phoenix are testing new therapies including novel drugs, biologics, and treatment approaches for heart disease.

Data updated March 2, 2026 from ClinicalTrials.gov